NetworkNewsBreaks – Imagin Medical Inc.’s (CSE

NetworkNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Innovative System Expected to Lead to More Successful Surgical Outcomes

Imagin Medical (CSE: IME) (OTCQB: IMEXF) has developed and patented its i/Blue Imaging System(TM), which will directly address the problems associated with treating early stage bladder cancer using existing cystoscope technology. “Current technology shows only one image at a time, requiring the surgeon to constantly switch back and forth between the white and blue light images. The switching process makes orientation and navigation within the bladder a challenge for surgeons,” explains a recent article. Imagin’s system will display real-time white and blue light images simultaneously, side-by-side, removing the challenge of constantly switching and reorienting. In addition, unlike current BLC technology, the i/Blue Imaging System will adapt to most endoscopes on the market. “With this major roadblock removed, Imagin believes its i/Blue Imaging System will expand the adoption of BLC and lead to more successful surgical outcomes, with the potential of and fewer recurrences of this notoriously stubborn and expensive cancer.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer